SCHEMBL6708809

SCHEMBL6708809

N#Cc1cccc(C(=O)Nc2cccc3cc(C(=O)Nc4ccc(Br)cc4-c4noc(=O)[nH]4)[nH]c23)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.39
GRIK1 P39086 1/20 0.38
GRM5 P41594 2/20 0.37
RXFP1 Q9HBX9 2/20 0.36
PDE10A Q9Y233 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
BRAF P15056 1/20 0.35
AKR1C4 P17516 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HIF1A Q16665 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GPR35 Q9HC97 3/20 0.34
HDAC1 Q13547 1/20 0.34
KDR P35968 1/20 0.34
DHODH Q02127 1/20 0.34
S1PR3 Q99500 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710055 0.94 IRAK4 (0.41) IRAK4GRM5RXFP1PDE10ANR1H4
SCHEMBL6711406 0.93 GRIK1 (0.38) GRIK1RXFP1NR1H4TDP1GPR35
SCHEMBL6710389 0.91 MEN1 (0.40) IRAK4GRIK1GRM5RXFP1BRAF
SCHEMBL6713760 0.90 GRIK1 (0.42) GRIK1RXFP1AKR1C4AKR1C3AKR1C2
SCHEMBL6708679 0.90 GRIK1 (0.44) GRIK1RXFP1TDP1HIF1ANPSR1
SCHEMBL6708854 0.89 KMT2A (0.42) IRAK4RXFP1PDE10ANR1H4HDAC1
SCHEMBL6712044 0.88 GPR35 (0.46) GRIK1RXFP1GPR35
SCHEMBL6709159 0.87 TP53 (0.39) IRAK4GRM5RXFP1GPR35HDAC1
SCHEMBL6713931 0.86 GRIK1 (0.41) GRIK1RXFP1NR1H4TDP1HIF1A
SCHEMBL6711934 0.85 PRSS12 (0.39) RXFP1NR1H4S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 IRAK4 1592/4885GRIK1 3885/4885GRM5 4139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.